These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 994690)

  • 1. [Delayed-action peruincamine forte in geriatrics].
    Denceux P
    Lille Med; 1976 Sep; 21(7 Suppl 3):606-9. PubMed ID: 994690
    [No Abstract]   [Full Text] [Related]  

  • 2. [Strong delayed-action pervincamine in general medicine].
    Warembourg H; Ketelers JY
    Lille Med; 1975 Apr; 20(4):424-7. PubMed ID: 1152596
    [No Abstract]   [Full Text] [Related]  

  • 3. [Delayed-action pervincamine forte in circulatory disorders of the posterior segment of the eye].
    Bregeat P; Ryzman P
    Rev Otoneuroophtalmol; 1975; 47(5):353-8. PubMed ID: 1215739
    [No Abstract]   [Full Text] [Related]  

  • 4. [Report of a trial with Pervincamine Forte Retard in 50 cases of various otological disorders].
    Oudot J
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1978 May; 27(5):361-5. PubMed ID: 149837
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advantages of delayed-action Pervincamine Forte in the prevention of altitude sickness].
    Adenis L
    Lille Med; 1978 May; 23(5 Suppl 1):382-3. PubMed ID: 682848
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effectiveness of Cavinton in retinal and choroid circulatory disturbances: I. Review of literature and material elaboration (author's transl)].
    Swietliczkowa I; Zeydler-Grzedzielewska L; Baszczyńska-Zielińska B; Braciak W
    Klin Oczna; 1980 Mar; 82(3):147-8. PubMed ID: 7392516
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic action of Cavinton in hearing defects of neurological origin.
    Ordögh B; Sárossy D; Klimstein G
    Ther Hung; 1978; 26(1):16-9. PubMed ID: 663871
    [No Abstract]   [Full Text] [Related]  

  • 8. [Controlled clinical study on the activity of vincamine-teprosylate in the so-called aging brain syndrome].
    Passeri M; Cucinotta D; Mancini M; Bia A; Palummeri E
    G Clin Med; 1982; 63(11-12):874-87. PubMed ID: 7182206
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effectiveness of cavinton in retinal and choroid circulatory disturbances: II. Results of own investigations and discussion (author's transl)].
    Swietliczkowa I; Zeydler-Grzedzielewska L; Baszczyńska-Ziellińska B; Braciak W
    Klin Oczna; 1980 Mar; 82(3):149-52. PubMed ID: 7392517
    [No Abstract]   [Full Text] [Related]  

  • 10. [Controlled multicenter clinical studies on the effect of (-)eburnamonine versus placebo in patients with chronic senile cerebral insufficiency of medium significance].
    Aveni-Casucci MA; Canal N; Corsico R; Passeri M; Porro A; Ventura A
    G Clin Med; 1983; 64(9-10):372-94. PubMed ID: 6363189
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pervincamine in the treatment of the cerebrovascular syndrome in the gerontopsychiatric patients].
    Fidetzis K; Brosteano R; Keller P
    Med Welt; 1976 Jul; 27(29):1412-4. PubMed ID: 785150
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiences on the treatment of cerebral insufficiency and peripheral circulation disorders with the test preparation EP 50-100].
    Bock KJ
    Med Welt; 1972 Feb; 23(8):273-5. PubMed ID: 5012543
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of the anti-platelet aggregation action of oxovinca in the diffuse vascular deterioration syndrome].
    Jubert Gruart J; Canals R; Balaguer M
    Med Clin (Barc); 1983 Jan; 80(1):10-2. PubMed ID: 6834913
    [No Abstract]   [Full Text] [Related]  

  • 14. An update on vinpocetine: New discoveries and clinical implications.
    Zhang YS; Li JD; Yan C
    Eur J Pharmacol; 2018 Jan; 819():30-34. PubMed ID: 29183836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic, recurrent, cervical-spine syndrome. Therapeutic observations with vincamin-depot].
    Kühle A
    ZFA (Stuttgart); 1979 Jan; 55(3):188-91. PubMed ID: 419815
    [No Abstract]   [Full Text] [Related]  

  • 16. [The treatment of hypertension patients with neurological disorders].
    Zozulia IS; Zozulia AA; Shevchenko VA; Buslo EA; Galusha AI
    Vrach Delo; 1990 Oct; (10):58-60. PubMed ID: 1981956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of vascular retinal lesions with Cavinton (author's transl)].
    Oláh Z; Potocký M
    Cesk Oftalmol; 1981 Jan; 37(1):19-23. PubMed ID: 7471250
    [No Abstract]   [Full Text] [Related]  

  • 18. [A special flicker fusion frequency method for detection of the effects of gerontopharmaceuticals exemplified by the L-eburnamonine study].
    Plörer S; Gerstenbrand F; Lehmann HE; Saltuari L; Stralkowski E
    Psychiatr Neurol Med Psychol (Leipz); 1985 Nov; 37(11):635-42. PubMed ID: 4089045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problems of treating autonomic disorders accompanying vascular dystonias].
    Panikarskiĭ VG
    Vrach Delo; 1978 Sep; (9):39-42. PubMed ID: 706318
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical trial of a delayed-action preparation of beta pyridyl-carbinol in vascular pathology].
    Warembourg H; Thery C
    Lille Med; 1970 Apr; 15(4 Suppl 3):599-602. PubMed ID: 5424406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.